Financial results - RIVAPHARM SRL

Identification data, financial results - Rivapharm Srl

Unique identification code: 14280474
Registration number: J09/408/2001
CAEN: 4773
Sales - Ron
478.660
Net Profit - Ron
5.398
Employee
10
For a more advanced analysis and a comparison with the industry the company belongs to, open a customer account and view the financial reports: Financial Rating, Payment Limits, Probability of Insolvency, Market Share or Competition.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Rivapharm Srl

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Sales - EUR 393.874 354.635 334.370 357.738 375.681 437.620 455.297 491.388 432.503 478.660
Total Income - EUR 428.435 368.886 337.489 360.228 379.924 458.659 461.709 492.910 434.037 483.922
Total Expenses - EUR 374.106 373.677 358.478 350.202 369.036 449.961 453.679 478.127 427.780 478.524
Gross Profit/Loss - EUR 54.329 -4.791 -20.990 10.026 10.888 8.698 8.030 14.784 6.256 5.398
Net Profit/Loss - EUR 45.637 -4.791 -20.990 8.421 6.032 5.336 6.745 12.560 6.256 5.398
Employees 8 9 10 9 11 10 9 10 10 10
Check the financial evolution reflected in Turnover, Profit, number of employees, companies' debts over the last 10 years and make informed business decisions.

Check the financial reports for the company - Rivapharm Srl

Rating financiar

Financial Rating -
Rivapharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Rivapharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Rivapharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Rivapharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports

Debts, Equity, Inventories, Receivables, Accounts, Assets - Rivapharm Srl - CUI 14280474

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Fixed Assets 43.188 133.445 126.009 119.469 112.310 99.977 97.176 94.541 83.904 74.333
Current Assets 282.109 164.213 113.663 157.705 169.804 141.904 152.466 178.127 168.138 150.411
Inventories 82.279 71.699 62.087 71.997 64.678 62.105 75.294 82.567 89.532 57.240
Receivables 76.101 74.916 59.698 77.531 94.931 61.164 51.822 60.390 52.427 59.843
House and accounts 123.729 17.599 -8.122 8.177 10.195 18.634 25.349 35.170 26.178 21.160
Own Capitals 100.370 95.638 75.446 83.098 87.965 107.310 106.562 117.102 120.761 126.534
Social Capital 45 45 45 45 44 15.666 9.946 9.758 9.542 9.571
Liability 224.927 202.021 164.226 194.077 194.148 134.571 143.080 155.567 131.280 98.210
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821 4.4847
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
Search for any company and analyze the financial data as well as the indicators generated based on them.
For a more advanced analysis and a comparison with the industry the company belongs to, open a customer account and view the financial reports: Financial Rating, Payment Limits, Probability of Insolvency, Market Share or Competition.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Reports that can be accessed based on the subscription:

  • Financial Rating
  • Payment Limits
  • Outstanding Debts
  • Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.

Reviews - Rivapharm Srl

Comments - Rivapharm Srl